ALTAO
Aton operates as a bioscience company in France. It engages in drug development, preclinical and clinical services, production of monoclonal antibodies, laboratory equipment production, and designing and manufacturing of medical devices, as well as provision of human tissues. The company also offers medical devices for surgeons, powered by Stemcis. The company was founded in 1998 and is headquart… Read more
ALTAO (ALTAO) - Total Liabilities
Latest total liabilities as of June 2025: €5.21 Million EUR
Based on the latest financial reports, ALTAO (ALTAO) has total liabilities worth €5.21 Million EUR as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ALTAO - Total Liabilities Trend (2009–2024)
This chart illustrates how ALTAO's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ALTAO Competitors by Total Liabilities
The table below lists competitors of ALTAO ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Stern Groep N.V.
AS:PBH
|
Netherlands | €370.00K |
|
Drago entertainment S.A.
WAR:DGE
|
Poland | zł2.25 Million |
|
NRB Industrial Bearings Limited
NSE:NIBL
|
India | ₹1.67 Billion |
|
OZZ Resources Ltd
AU:OZZ
|
Australia | AU$520.00K |
|
Nuinsco Resources Limited
PINK:NWIFF
|
USA | $3.48 Million |
|
SEATech Ventures Corp
PINK:SEAV
|
USA | $381.63K |
|
Scisparc Ltd
NASDAQ:SPRC
|
USA | $5.22 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down ALTAO's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.33 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 12.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.93 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ALTAO's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ALTAO (2009–2024)
The table below shows the annual total liabilities of ALTAO from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €5.66 Million | -0.99% |
| 2023-12-31 | €5.72 Million | +15.05% |
| 2022-12-31 | €4.97 Million | +33.59% |
| 2021-12-31 | €3.72 Million | +145.00% |
| 2020-12-31 | €1.52 Million | +122.70% |
| 2019-12-31 | €681.70K | -74.87% |
| 2018-12-31 | €2.71 Million | -43.65% |
| 2017-12-31 | €4.81 Million | -9.17% |
| 2016-12-31 | €5.30 Million | -0.49% |
| 2015-12-31 | €5.33 Million | -10.34% |
| 2014-12-31 | €5.94 Million | +8.57% |
| 2013-12-31 | €5.47 Million | -3.97% |
| 2012-12-31 | €5.70 Million | -15.71% |
| 2011-12-31 | €6.76 Million | -7.28% |
| 2010-12-31 | €7.29 Million | +28.41% |
| 2009-12-31 | €5.68 Million | -- |